The FLU-PRO is a self-administered patient-reported outcome measure (PRO) to quantify symptom severity in influenza and influenza-like illness. The instrument was developed by a team of academic investigators spanning multiple sites across many countries under the direction of Dr. John H. Powers of George Washington University and the University of Maryland and with the assistance of Evidera’s Patient-Centered Research staff. Copyright, licensing, and oversight of the FLU-PRO are managed by Leidos Biomedical Research. Information on the FLU-PRO is provided as a public service.

Continue scrolling to find out more about: